Presentation ISCTR 2016 Current Challenges to and Future Direction of US Early Feasibility Studies FDA Point of View Presenter: Andrew Farb October 28, 2016 REGISTER for free or LOG IN to view this content Policy & Practice Guidelines Presentation ISCTR 2016 Up Next Presentation ISCTR 2016 Requirements for Medical Device Manufacturing and Iteration: FDA Point of Views Presenter: Bradley Quinn October 28, 2016 More slides + Presentation ISCTR 2016 Optimal Pre-Clinical Study Design and Endpoints for Device Evaluation Presenter: Judith A. Davis October 28, 2016 Presentation ISCTR 2016 Challenges and Future Direction for Human Early Feasibility Device Evaluation: Industry Point of View Presenter: David G. Reuter October 28, 2016 We Recommend
Presentation ISCTR 2016 Requirements for Medical Device Manufacturing and Iteration: FDA Point of Views Presenter: Bradley Quinn October 28, 2016
Presentation ISCTR 2016 Optimal Pre-Clinical Study Design and Endpoints for Device Evaluation Presenter: Judith A. Davis October 28, 2016
Presentation ISCTR 2016 Challenges and Future Direction for Human Early Feasibility Device Evaluation: Industry Point of View Presenter: David G. Reuter October 28, 2016